Project Grant R44PS005271
Award Date 9/30/25
Completion Date 9/29/27
Dollars Obligated $995K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Rockville, MD, USA
Similar Awards
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $233,666 Project Grant to Esper Biosciences Inc. in Ithaca, NY on September 30, 2025 under the CDC Investigations and Technical Assistance program (CFDA 93.283). The grant funding supports the development of a rapid point-of-care nucleic acid test for Hepatitis C using nanosensors. This project aligns with the CDC program's goals of controlling communicable diseases and developing innovative health technologies. The award has...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,047,807 Project Grant under the CDC Investigations and Technical Assistance program (CFDA 93.283) to Nanohmics Inc., a small technology development company based in Austin, TX. The grant, with a performance period from September 30, 2025 to September 29, 2027, supports the development of Lateral Flow-Electrochemiluminescent (LF-ECL) test strips and a portable reader system for ultrasensitive detection of foodborne...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $279,270 Project Grant to Advanced Virology Inc. in Philadelphia, PA on September 30, 2025. The grant, funded through the CDC's Investigations and Technical Assistance program (CFDA 93.283), supports the development of "LOW-COST AND HIGH EFFICIENCY DNA-BASED REVERSE GENETICS PLATFORMS FOR MANUFACTURING RNA VIRUS PRODUCTS." The project aims to advance technologies for the production of RNA virus-based products through...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $265,850 Project Grant to SKM Instruments, LLC on Sep 30, 2025 under the CDC Investigations and Technical Assistance program (CFDA 93.283). The grant supports the development of an ULTRA-RAPID OPTICAL PLATFORM FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING (AST) OF PULMONARY NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS. The project aims to create an innovative health technology to enhance disease detection and prevention...
- This Project Grant award, totaling $354,570.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award aims to develop a cost-effective and user-friendly point-of-care (POC) diagnostic tool, employing a novel "CamoChip" technology, for highly sensitive and multiplex testing of biomarkers related to HIV/HBV co-infection. The key products and services to be delivered under...
- The Centers for Disease Control and Prevention (CDC) awarded a $300,000 Project Grant to Pace Diagnostics, Inc. under the CDC Investigations and Technical Assistance program (CFDA 93.283). The funding will support the development of an ultrasensitive urine tuberculosis (TB) antigen rapid detection test for the diagnosis of active TB. The project period is from Sep 30, 2025 to Mar 31, 2026. The CDC Investigations and Technical Assistance program funds research, surveillance, epidemiological...
- The National Heart Lung and Blood Institute (NHLBI), under CFDA Program 93.837 Cardiovascular Diseases Research, awarded a $3,519,835 Project Grant to the Scripps Research Institute in La Jolla, CA on September 5, 2025. The grant, titled "PLANB2CUREHIV (THE 'PLANB' CONSORTIUM) - PROJECT SUMMARY", aims to accelerate the preclinical development of safe and effective genome-edited B cell-based therapies that could provide long-lasting, broadly neutralizing antibody titers capable of...
- This $118,488 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) on January 20, 2025, supports research to develop HIV-resistant hematopoietic stem cells through targeted base editing. The project aims to identify genetic mutations in the CCR5 and CXCR4 co-receptors that can prevent HIV entry into CD4 cells while maintaining the central functions of these proteins in hematopoiesis. The research involves...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support the development of a novel universal rapid test for HIV diagnosis. IGE Immunodiagnostics & Therapeutics, LLC, a minority-owned small business, will receive $294,948 to adapt their existing HIV ELISA test into a 5th generation antigen/antibody combination rapid test format. The goal is to create a simple, rapid,...
- This $399,935 National Science Foundation (NSF) Project Grant Award under the Computer and Information Science and Engineering program (CFDA 47.070) aims to develop a portable and cost-effective biomedical diagnostic system in the form of an integrated lab-on-a-chip platform produced using additive manufacturing techniques. The key products and services to be delivered include: Advancing 3D manufacturing techniques, particularly in electrode printing, to enhance fabrication precision and...